Mackenzie Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.96M | Sell |
9,075
-410
| -4% | -$134K | ﹤0.01% | 700 |
|
|
2025
Q1 | $2.56M | Buy |
9,485
+626
| +7% | +$169K | ﹤0.01% | 706 |
|
|
2024
Q4 | $2.08M | Sell |
8,859
-10,832
| -55% | -$2.55M | ﹤0.01% | 759 |
|
|
2024
Q3 | $5.42M | Sell |
19,691
-16,400
| -45% | -$4.51M | 0.01% | 531 |
|
|
2024
Q2 | $8.77M | Buy |
36,091
+17,576
| +95% | +$4.27M | 0.01% | 457 |
|
|
2024
Q1 | $2.77M | Sell |
18,515
-1,821
| -9% | -$272K | ﹤0.01% | 670 |
|
|
2023
Q4 | $3.89M | Sell |
20,336
-1,410
| -6% | -$270K | 0.01% | 604 |
|
|
2023
Q3 | $3.76M | Sell |
21,746
-8,350
| -28% | -$1.44M | 0.01% | 591 |
|
|
2023
Q2 | $5.71M | Buy |
30,096
+4,299
| +17% | +$815K | 0.01% | 528 |
|
|
2023
Q1 | $5.17M | Buy |
25,797
+580
| +2% | +$116K | 0.01% | 540 |
|
|
2022
Q4 | $5.99M | Buy |
25,217
+1,703
| +7% | +$405K | 0.01% | 492 |
|
|
2022
Q3 | $4.71M | Buy |
23,514
+2,508
| +12% | +$502K | 0.01% | 540 |
|
|
2022
Q2 | $3.06M | Buy |
21,006
+1,630
| +8% | +$238K | ﹤0.01% | 626 |
|
|
2022
Q1 | $3.16M | Buy |
19,376
+1,965
| +11% | +$321K | ﹤0.01% | 671 |
|
|
2021
Q4 | $2.95M | Buy |
17,411
+1,756
| +11% | +$298K | ﹤0.01% | 683 |
|
|
2021
Q3 | $2.96M | Buy |
15,655
+2,915
| +23% | +$550K | ﹤0.01% | 674 |
|
|
2021
Q2 | $2.16M | Buy |
12,740
+1,651
| +15% | +$280K | ﹤0.01% | 708 |
|
|
2021
Q1 | $1.57M | Buy |
11,089
+1,601
| +17% | +$226K | ﹤0.01% | 729 |
|
|
2020
Q4 | $1.23M | Sell |
9,488
-419
| -4% | -$54.5K | ﹤0.01% | 682 |
|
|
2020
Q3 | $1.44M | Sell |
9,907
-7,131
| -42% | -$1.04M | ﹤0.01% | 609 |
|
|
2020
Q2 | $2.52M | Buy |
17,038
+13,394
| +368% | +$1.98M | 0.01% | 507 |
|
|
2020
Q1 | $397K | Buy |
3,644
+865
| +31% | +$94.2K | ﹤0.01% | 841 |
|
|
2019
Q4 | $320K | Buy |
+2,779
| New | +$320K | ﹤0.01% | 946 |
|
|
2019
Q3 | – | Sell |
-5,075
| Closed | -$368K | – | 1008 |
|
|
2019
Q2 | $368K | Sell |
5,075
-6,918
| -58% | -$502K | ﹤0.01% | 911 |
|
|
2019
Q1 | $1.12M | Buy |
11,993
+5,794
| +93% | +$542K | ﹤0.01% | 898 |
|
|
2018
Q4 | $452K | Sell |
6,199
-32,096
| -84% | -$2.34M | ﹤0.01% | 954 |
|
|
2018
Q3 | $3.35M | Buy |
38,295
+33,911
| +774% | +$2.97M | 0.01% | 557 |
|
|
2018
Q2 | $432K | Sell |
4,384
-12,881
| -75% | -$1.27M | ﹤0.01% | 816 |
|
|
2018
Q1 | $2.06M | Buy |
+17,265
| New | +$2.06M | 0.01% | 560 |
|